Page last updated: 2024-10-30

metformin and Chronic Primary Open Angle Glaucoma

metformin has been researched along with Chronic Primary Open Angle Glaucoma in 6 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"To determine whether the caloric restriction mimetic drug metformin hydrochloride is associated with reduced risk of open-angle glaucoma (OAG) in persons with diabetes mellitus."7.81Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus. ( Childers, D; Lin, HC; Nan, B; Newman-Casey, PA; Richards, JE; Stein, JD; Thompson, DA, 2015)
"Recent studies suggest that the diabetes drug metformin has a protective effect on open-angle glaucoma (OAG) and age-related macular degeneration (AMD)."4.12Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study. ( Ahmadizar, F; Kavousi, M; Klaver, CCW; Ramdas, WD; Stricker, BH; Thee, EF; van Duijn, CM; Vergroesen, JE, 2022)
" The association between the subjects who were on metformin for treatment of diabetes mellitus and development of incident POAG was assessed."4.02Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study. ( Asokan, R; George, R; Vijaya, L, 2021)
"To determine whether the caloric restriction mimetic drug metformin hydrochloride is associated with reduced risk of open-angle glaucoma (OAG) in persons with diabetes mellitus."3.81Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus. ( Childers, D; Lin, HC; Nan, B; Newman-Casey, PA; Richards, JE; Stein, JD; Thompson, DA, 2015)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's5 (83.33)2.80

Authors

AuthorsStudies
George, R1
Asokan, R1
Vijaya, L1
Kumar, N1
Amin, SV1
Khanna, S1
Parvar, SP1
Shaw, LT1
Dao, D1
Hariprasad, SM1
Skondra, D1
Vergroesen, JE1
Thee, EF1
Ahmadizar, F1
van Duijn, CM1
Stricker, BH1
Kavousi, M1
Klaver, CCW1
Ramdas, WD1
Xu, L1
Zhang, X1
Zhao, Y1
Gang, X1
Zhou, T1
Han, J1
Cao, Y1
Qi, B1
Song, S1
Wang, X1
Liang, Y1
Lin, HC1
Stein, JD1
Nan, B1
Childers, D1
Newman-Casey, PA1
Thompson, DA1
Richards, JE1

Reviews

1 review available for metformin and Chronic Primary Open Angle Glaucoma

ArticleYear
Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature.
    Experimental biology and medicine (Maywood, N.J.), 2022, Volume: 247, Issue:4

    Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glaucoma, Open-Angle; Macular Degeneration

2022

Other Studies

5 other studies available for metformin and Chronic Primary Open Angle Glaucoma

ArticleYear
Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study.
    Indian journal of ophthalmology, 2021, Volume: 69, Issue:11

    Topics: Cohort Studies; Diabetes Mellitus; Glaucoma, Open-Angle; Humans; Incidence; India; Intraocular Press

2021
Commentary - Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study.
    Indian journal of ophthalmology, 2021, Volume: 69, Issue:11

    Topics: Cohort Studies; Diabetes Mellitus; Glaucoma, Open-Angle; Humans; Incidence; India; Intraocular Press

2021
Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.
    JAMA ophthalmology, 2022, 07-01, Volume: 140, Issue:7

    Topics: Aged; Cataract; Cohort Studies; Diabetes Mellitus, Type 2; Female; Glaucoma, Open-Angle; Humans; Ins

2022
Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals.
    eLife, 2023, 01-04, Volume: 12

    Topics: Animals; Cells, Cultured; Glaucoma; Glaucoma, Open-Angle; Humans; Integrins; Metformin; Mice; Ocular

2023
Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus.
    JAMA ophthalmology, 2015, Volume: 133, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Biomimetics; Blood Glucose; Caloric Restriction; Diabetes Mellitus;

2015